Glimnew MV 3/0.3 Tablet SR
Marketer
Genexwell Biotech
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimnew MV 3/0.3 Tablet SR
Glimnew MV 3/0.3 SR tablets are antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. They regulate blood glucose. Always take this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medicine is one component of a comprehensive diabetes management plan, encompassing a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Glimnew MV 3/0.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimnew MV 3/0.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or fracture it. Administer Glimnew MV 3/0.3 Tablet SR on an empty stomach.
Common Side effects of Glimnew MV 3/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimnew MV 3/0.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimnew MV 3/0.3 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication on an empty stomach.
How Glimnew MV 3/0.3 Tablet SR works:
Glimnew MV 3/0.3mg sustained-release tablets contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimnew MV 3/0.3 Tablet SR and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimnew MV 3/0.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimnew MV 3/0.3mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Glimnew MV 3/0.3 Tablet SR is inadvisable for individuals with kidney impairment and should be strictly avoided. Medical advice is essential. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimnew MV 3/0.3 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A low starting dose is generally recommended for those with mild to moderate liver disease; use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimnew MV 3/0.3 Tablet SR :
Should you forget to take a Glimnew MV 3/0.3 Tablet SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimnew MV 3/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




